本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Olema Pharmaceuticals, Inc.

5.16
+0.12002.38%
盤後5.240.0800+1.55%17:20 EDT
成交量:70.68萬
成交額:363.12萬
市值:3.53億
市盈率:-2.34
高:5.25
開:4.98
低:4.95
收:5.04
資料載入中...
2025/03/19

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/19

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/19

重要事件披露

Form 8-K - Current report
2025/03/05

重要事件披露

Form 8-K - Current report
2025/01/13

SEC問詢函

Form CORRESP - Correspondence
2025/01/13

SEC問詢函

Form CORRESP - Correspondence
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/10

重要事件披露

Form 8-K - Current report
2024/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/11

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities